Platelet-rich plasma (PRP) therapy has been widely applied in various medical fields
including humans and horses. This study aimed to establish an optimal activation method to
stably and reproducibly maximize the concentrations of platelet-derived growth factor-BB
(PDGF-BB) and transforming growth factor-β1 (TGF-β1) contained in equine PRP. Autologous
PRP was prepared from 11 Thoroughbreds. For the activation test, PRP was activated by
either a single freeze-thaw cycle (
Fr
) or adding calcium and autologous
serum containing thrombin (
Ca
). PDGF-BB and TGF-β1 concentrations in
Fr
,
Ca
, nonactivated (
No
), and
platelet-poor plasma (PPP) samples were determined using ELISA and compared. For
repetitive freeze-thaw test, PRP was subjected to single (
Fr1
), double
(
Fr2
), triple (
Fr3
), or quadruple
(Fr4
) freeze-thaw cycles and the concentrations of both growth factors
in samples were compared similarly. The PDGF-BB concentration in
Ca
was
significantly higher than that in other preparations. The TGF-β1 concentrations in
Fr
and
Ca
were significantly higher than those in PPP
and
No
, with no significant differences between
Fr
and
Ca
. The concentrations of both factors were significantly increased in
PRP treated with multiple cycles of freeze-thaw compared with that in PRP treated with a
single cycle. No significant differences were noted among
Fr2
,
Fr3
, and
Fr4
. Our findings suggest that activation by
adding calcium and autologous serum is optimal for instant use of PRP and that double
freeze-thawing is an easier and optimal activation method for cryopreserved PRP.